- Fund close exceeds initial target despite a challenging fundraising environment, reflecting strong investor confidence in India and Southeast Asia healthcare
- Existing investors increased commitment amount by an average of 80%
- New capital raised from blue-chip global institutions, alongside a significant rise in Asian investor participation
The oversubscribed fundraise comprises over US$954 million in primary commitments and US$114 million in committed co-investment capital. An additional US$300 million co-investment capacity is anticipated over the course of the investment phase, bringing total committed capital to approximately US$1.3 billion upon full deployment.
This latest fundraise is around 60% larger than the firm’s previous $600m fund raised in 2020, cementing Quadria’s position as the largest dedicated healthcare private equity fund in South and Southeast Asia.
“Fund III’s close, amid one of the most demanding fundraising climates in recent memory, is a powerful validation of our strategy and our mission,” said Abrar Mir, Co-Founder and Managing Partner, Quadria Capital. “It reflects deep global investor conviction in the transformational opportunity in Asian Healthcare, where social impact and financial performance go hand in hand.”
Global Institutional Backing Across Continents
At a time when global capital is cautious, Quadria’s ability to consistently attract top-tier global investors underscores the strong conviction in its investment strategy and the undeniable opportunities in the Asian healthcare market.
Quadria Capital’s largest existing backers include prominent North American and European sovereign wealth funds, asset managers, and strategic corporates. The Fund also secured new commitments from globally recognized institutional investors. Most notably, there was strong backing from leading institutions across the GCC, including Saudi Arabia, the UAE, and Bahrain. The fundraise further attracted interest from India, with fresh capital from major banks, insurance companies, and family offices. Additionally, the Fund received robust re-up commitments from impact investors - underscoring Quadria’s continued dedication to scalable, high-impact healthcare businesses that deliver lifesaving care to underserved populations across Asia.
Positioned for Structural Growth in Indonesia’s $50 Billion Healthcare Market
Indonesia, on track to become the world’s 7th largest economy by 2030, is seeing healthcare expenditure rise at a double-digit CAGR—driven by growing demand, rising incomes, and strong public and private investment. As the country shifts from basic access to quality and innovation, Quadria is deepening its commitment with the opening of a new office in Jakarta, reinforcing Indonesia’s role as a strategic priority for the firm, and has recently recruited seasoned executive Raymond Rudianto to join as Managing Director and Head of Indonesia in June to lead Quadria’s business there.
“We are excited to welcome Raymond to the firm to establish our on the ground presence – Indonesia has been and very much continues to be a strategic priority for Quadria,” said Ewan Davis, Partner, Quadria Capital.
Quadria’s portfolio includes Hermina Hospital, the largest BPJS-focused hospital group in the country, with 51 hospitals and growing, serving nearly 10 million patients annually. As the nation’s leading provider of subsidised healthcare, Hermina plays a vital role in delivering affordable, quality care at scale.
“Our investment in Hermina underscores our belief that the power of scale and operational excellence can deliver affordable and quality healthcare outcomes across Indonesia,” added Ewan Davis. This builds on Quadria’s successful track record in the market, including its prior investment and exit from SOHO Global Health, one of Indonesia’s largest integrated pharmaceutical companies.
About Quadria:
Founded in 2012, Quadria Capital is Asia’s premier healthcare investor managing over US$4 billion in assets across 27 investments in South and Southeast Asia including India, Vietnam, Indonesia, Malaysia and Singapore. Quadria Capital aims to create significant and sustainable shareholder value by partnering with exceptional healthcare businesses to enhance their impact and scale, while generating superior returns for investors.
For more information, please visit www.quadriacapital.com
Contacts
Media Contact:
Yvette Lim
Yvette.lim@fgsglobal.com
Source: Quadria Capital
Reporter: PR Wire
Editor: PR Wire
Copyright © ANTARA 2025
